(China) Key Points for Pharmacovigilance Inspections
https://baipharm.chemlinked.com/news/china-nmpa-announces-key-points-for-pharmacovigilance-inspections
E2B(R3) Individual Case Safety Report (ICSR) Specification and Related Files
https://www.ich.org/page/e2br3-individual-case-safety-report-icsr-specification-and-related-files
New EU regulation on clinical trials of medicinal products
https://ansm.sante.fr/actualites/entree-en-application-du-nouveau-reglement-europeen-relatif-aux-essais-cliniques-des-medicaments
Reporting safety information on clinical trials
https://www.ema.europa.eu/en/human-regulatory/research-development/clinical-trials/reporting-safety-information-clinical-trials
List of medicines under additional monitoring
https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/medicines-under-additional-monitoring/list-medicines-under-additional-monitoring
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 06-09 April 2022
https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-6-9-april-2021_en.pdf